Cargando…
GWAS and drug targets
BACKGROUND: Genome wide association studies (GWAS) have revealed a large number of links between genome variation and complex disease. Among other benefits, it is expected that these insights will lead to new therapeutic strategies, particularly the identification of new drug targets. In this paper,...
Autores principales: | Cao, Chen, Moult, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083410/ https://www.ncbi.nlm.nih.gov/pubmed/25057111 http://dx.doi.org/10.1186/1471-2164-15-S4-S5 |
Ejemplares similares
-
Insights from GWAS: emerging landscape of mechanisms underlying complex trait disease
por: Pal, Lipika R, et al.
Publicado: (2015) -
Integrating GWAS and proteome data to identify novel drug targets for MU
por: Wu, Yadong, et al.
Publicado: (2023) -
GWASeq: targeted re-sequencing follow up to GWAS
por: Salomon, Matthew P., et al.
Publicado: (2016) -
Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics
por: Lam, Max, et al.
Publicado: (2021) -
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
por: Lin, Wei-Zhi, et al.
Publicado: (2022)